Emergency Management of Atrial Fibrillation and Flutter: Intravenous Diltiazem Versus Intravenous Digoxin
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Emergency Medicine
- Vol. 29 (1), 135-140
- https://doi.org/10.1016/s0196-0644(97)70319-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of Internal Medicine, 1995
- Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.Circulation, 1992
- Management of Atrial FibrillationNew England Journal of Medicine, 1992
- Atrial Fibrillation 1992Chest, 1992
- A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter studyJournal of the American College of Cardiology, 1991
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Treatment of Atrial ArrhythmiasArchives of Internal Medicine, 1986
- Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.Cell Metabolism, 1986
- An “account” of digitalis and atrial fibrillationJournal of the American College of Cardiology, 1985